Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/2/2020
SIETES contiene 92904 citas

<< anterior 41 a 60 de 558 siguiente >>
Presentar resultados
Seleccionar todas
41. Cita con resumen
Sheldon T. Reduce use of antidepressants, Dutch doctors are told. BMJ 2012;344:5. [Ref.ID 93240]
42.Tiene citas relacionadas Cita con resumen
Oderda LH, Young JR, Asche CV, Pepper GA. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs . Ann Pharmacother 2012;46:917-28. [Ref.ID 92714]
43. Cita con resumen
44. Cita con resumen
Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Drug Saf 2012;35:245-59. [Ref.ID 92433]
45. Cita con resumen
Takahashi Y, Nishida Y, Asai S. Utilization of health care databases for pharmacoepidemiology. Eur J Clin Pharmacol 2012;68:123-9. [Ref.ID 92327]
46. Cita con resumen
Arbouw MEL, Movig KLL, Guchelaar H-J, Neef C, Egberts TCG. Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study. Eur J Clin Pharmacol 2012;68:83-8. [Ref.ID 92259]
47. Cita con resumen
Maxwell S, Eichler H-G, Bucsics A, Haefeli WE, Gustafsson LL. e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers. Br J Clin Pharmacol 2012;73:12-5. [Ref.ID 92246]
48. Cita con resumen
Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, Straus SM, Herings RM, Stricker BH. Lower risk of cancer in patients on metformin in comparison with those of sulfonylurea derivatives: results from a large population-based follow-up study. Diabetes Care 2012;35:119-24. [Ref.ID 92164]
49. Cita con resumen
Neubert A, Hsia Y, de Jong-van den Berg LTW, Janhsen K, Glaeske G, Furu K, Kieler H, Norgaard M, Clavenna A, Wong ICK. Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries. Br J Clin Pharmacol 2011;72:969-77. [Ref.ID 91877]
50.Tiene citas relacionadas Cita con resumen
Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strenghts of the disproportionality analysis of identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 2011;72:905-8. [Ref.ID 91873]
51. Cita con resumen
Appleby J. Which is the best health system in the world?. BMJ 2011;343:722-3. [Ref.ID 91736]
52.Tiene citas relacionadas Cita con resumen
Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, Dwyer-Lindgren L, Lofgren KT, Phillips D, Atkinson C, Lopez AD, Murray CJL. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 2011;378:1139-65. [Ref.ID 91511]
53.Tiene citas relacionadas
Byass P, Graham WJ. Grappling with uncertainties along the MDG trail. Lancet 2011;378:1119-20. [Ref.ID 91510]
54. Cita con resumen
Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LTW. Road traffic accidents and psychotropic medication use in the Netherlands: a case-control study. Br J Clin Pharmacol 2011;72:505-13. [Ref.ID 90996]
55.Enlace a cita original Cita con resumen
van Riet-Nales DA, de Jager KE, Schobben AFAM, Egberts TCG, Rademaker CMA. The availability and age-appropriateness of medicines authorized for children in the Netherlands. Br J Clin Pharmacol 2011;72:465-73. [Ref.ID 90993]
56.Enlace a cita original
Sen EF, Verhamme MC, Felisi M, Jong GW, Giaquinto C, Picelli G, Ceci A, Sturkenboom MCJM, on behalf of the TEDDY European Network of Excellence. Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age. Br J Clin Pharmacol 2011;71:943-50. [Ref.ID 90890]
58.Enlace a cita original Cita con resumen
Rodenburg EM, Stricker BHCH, Visser LE. Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. Br J Clin Pharmacol 2011;71:95-104. [Ref.ID 89966]
Broos N, van Puijenbroek EP, van Grootheest K. Fever following immunization with influenza A (H1N1) vaccine in children: a suvey-based study in the Netherlands. Drug Saf 2010;33:1109-15. [Ref.ID 89727]
van Puijenbroek EP, Broos N, van Grootheest K. Monitoring adverse events of the vaccionation campaign against influenza A (H1N1) in the Netherlands. Drug Saf 2010;33:1097-108. [Ref.ID 89726]
Seleccionar todas
<< anterior 41 a 60 de 558 siguiente >>